Bradsaúde (SAUD3) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Surpassed 8.8 million beneficiaries, with net addition of 55,000 Bradesco Dental SME lives in 3Q24 and 292,000 net new members in the last twelve months.
Net income for 3Q24 was R$142 million, up 15% year-over-year, with EPS of R$0.2591 (+16.1% YoY) and a 100% payout via dividends and interest on capital.
Adjusted EBITDA for 3Q24 was R$177 million, up 13% year-over-year, with margin expanding to 30.9%.
Maintained net cash of R$1.1 billion and zero debt, with ROE at 39%.
Recognized as a Great Place to Work and Top of Mind in dental plans for the 11th consecutive year.
Financial highlights
Net operating revenue was R$571 million in 3Q24 (+4.6% YoY), and R$2.23 billion in the last twelve months (+5.4% YoY).
Adjusted EBITDA margin reached 30.9% in 3Q24, with LTM adjusted EBITDA at R$683 million (margin 30.7%).
Net financial income in 3Q24 was R$27.4 million, up 41.7% year-over-year.
Dental loss ratio improved to 38% in 3Q24, down 5 p.p. YoY, supporting margin expansion.
Allowance for doubtful receivables remained stable at 2.3% of net revenue in 3Q24.
Outlook and guidance
SME and Individual plans continue to drive growth, with higher average ticket and margins, supported by exclusive bancassurance channels and digital transformation.
Digital initiatives maturing in 2024 are expected to reduce future CAPEX and improve SG&A efficiency in 2025 and 2026.
Expectation to maintain high profitability and a consolidated loss ratio below 40% in coming years.
Latest events from Bradsaúde
- Net income was R$1.3B in 1Q26, with 13M+ members and major hospital and digital expansion.SAUD3
Q1 20268 Jul 2026 - Revenue up 5.3%, net income up 4.1%, 83% payout, and strong net cash with zero debt.SAUD3
Q4 20256 Jul 2026 - Record SME growth and margin expansion drove strong revenue and net income gains.SAUD3
Q3 20256 Jul 2026 - Net income up 18.1% YoY, record EBITDA margin, and robust SME-driven growth.SAUD3
Q2 20256 Jul 2026 - Adjusted EBITDA margin rose to 38.3% in 1Q25, led by SME and Individual plan growth.SAUD3
Q1 20256 Jul 2026 - Revenue up 5.9%, net income R$539M, 97% payout, R$913M net cash, no debt.SAUD3
Q4 20242 Jul 2026 - 2Q24 delivered strong growth, record margins, and a 100% net income payout to shareholders.SAUD3
Q2 20242 Jul 2026 - High-margin, tech-focused dental insurer grows SME segment, sustains top dividends, and zero debt.SAUD3
Status update28 Jan 2026